Alantra acts as fairnesss opinion provider to TBS Group’s Board on Permira’s public offer
Value €91 million
On 12 May 2017, Permira announced a public offer to acquire 100% of the outstanding share capital of TBS Group at a price of 2.20 Euro per share, valuing the total outstanding capital of TBS Group at around 93 mil Euro.
TBS Group is a leading player in Europe of outsourced biomedical engineering services to hospitals and private clinics. TBS Group is listed on the Italian Stock Exchange, operates in 21 countries and has a headcount of 2,400 employees. The group reached €200m in consolidated revenues in 2016 and €21.3m EBITDA.
Alantra provided a fairnesss Opinion to TBS Group’s Board of directors in order to assess the financial adequacy of the public offer.
After this transaction, TBS Group will be integrated into Pantheon, a Permira owned leading independent pan-European healthcare provider of complete managed solutions for the lifecycle of healthcare technology. The combination of TBS Group and Pantheon will extend the service offering of the group, providing a wider variety of equipment services and products and strengthening Pantheon’s international business development in Europe.
Oct 2020Buy-side advisoryOct 2020SECTOR HealthcareService M&A
Oct 2020InvestmentOct 2020SECTOR HealthcareService Strategic Advisory
Sep 2020Buy-side advisoryValue CHF 435 millionSep 2020SECTOR HealthcareService M&AValue CHF 435 million
Sep 2020Sell-side advisorySep 2020SECTOR HealthcareService M&A